Pakistani (KSE) Healthcare Sector Analysis
UpdatedJun 06, 2023
DataAggregated Company Financials
Companies14
- 7D0.3%
- 3M-6.0%
- 1Y-33.6%
- YTD-14.9%
Over the last 7 days, the Healthcare industry has dropped 1.4%, driven by GlaxoSmithKline Pakistan declining 2.2%. Overall the industry is down 35% in 12 months. Looking forward, earnings are forecast to grow by 74% annually.
Sector Valuation and Performance
Has the Pakistani Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 06 Jun 2023 | PK₨148.5b | PK₨230.4b | PK₨11.0b | 12x | 13.5x | 0.6x |
| Thu, 04 May 2023 | PK₨155.1b | PK₨217.8b | PK₨14.9b | 8.8x | 10.4x | 0.7x |
| Sat, 01 Apr 2023 | PK₨157.6b | PK₨214.7b | PK₨16.5b | 9x | 9.5x | 0.7x |
| Mon, 27 Feb 2023 | PK₨156.3b | PK₨211.8b | PK₨16.8b | 8.6x | 9.3x | 0.7x |
| Wed, 25 Jan 2023 | PK₨153.7b | PK₨211.8b | PK₨16.8b | 8.7x | 9.1x | 0.7x |
| Fri, 23 Dec 2022 | PK₨175.7b | PK₨210.9b | PK₨16.9b | 9.2x | 10.4x | 0.8x |
| Sun, 20 Nov 2022 | PK₨207.0b | PK₨210.0b | PK₨16.6b | 11.1x | 12.5x | 1x |
| Tue, 18 Oct 2022 | PK₨217.3b | PK₨202.0b | PK₨18.9b | 11.4x | 11.5x | 1.1x |
| Thu, 15 Sep 2022 | PK₨222.9b | PK₨193.0b | PK₨20.3b | 10.4x | 11x | 1.2x |
| Sat, 13 Aug 2022 | PK₨233.5b | PK₨189.9b | PK₨23.3b | 9.9x | 10x | 1.2x |
| Mon, 11 Jul 2022 | PK₨237.5b | PK₨188.5b | PK₨23.1b | 10.2x | 10.3x | 1.3x |
| Wed, 08 Jun 2022 | PK₨226.0b | PK₨185.8b | PK₨23.1b | 9.5x | 9.8x | 1.2x |
| Fri, 06 May 2022 | PK₨249.4b | PK₨185.3b | PK₨23.1b | 10.1x | 10.8x | 1.3x |
| Sun, 03 Apr 2022 | PK₨256.8b | PK₨181.2b | PK₨21.4b | 11.2x | 12x | 1.4x |
| Tue, 01 Mar 2022 | PK₨255.7b | PK₨180.0b | PK₨21.5b | 11.8x | 11.9x | 1.4x |
| Thu, 27 Jan 2022 | PK₨262.9b | PK₨180.0b | PK₨21.5b | 11.9x | 12.2x | 1.5x |
| Sat, 25 Dec 2021 | PK₨263.8b | PK₨180.0b | PK₨21.5b | 12.4x | 12.3x | 1.5x |
| Mon, 22 Nov 2021 | PK₨287.9b | PK₨179.9b | PK₨21.5b | 13.3x | 13.4x | 1.6x |
| Wed, 20 Oct 2021 | PK₨292.0b | PK₨173.6b | PK₨20.7b | 14.6x | 14.1x | 1.7x |
| Fri, 17 Sep 2021 | PK₨303.4b | PK₨170.6b | PK₨19.1b | 16.6x | 15.8x | 1.8x |
| Sun, 15 Aug 2021 | PK₨312.3b | PK₨170.6b | PK₨19.1b | 19.5x | 16.3x | 1.8x |
| Thu, 10 Jun 2021 | PK₨291.0b | PK₨157.5b | PK₨17.3b | 17x | 16.8x | 1.8x |
| Wed, 03 Mar 2021 | PK₨305.6b | PK₨151.9b | PK₨15.5b | 16.7x | 19.7x | 2x |
| Sat, 05 Dec 2020 | PK₨280.5b | PK₨148.4b | PK₨13.6b | 21.2x | 20.7x | 1.9x |
| Tue, 08 Sep 2020 | PK₨296.8b | PK₨142.0b | PK₨12.3b | 25.8x | 24.1x | 2.1x |
Price to Earnings Ratio
20.9x
Current Industry PE
- Investors are relatively neutral on the Pakistani Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 14.5x.
- The 3-year average PS ratio of 1.5x is higher than the industry's current PS ratio of 0.64x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 3.7% per year over the last three years.
- Meanwhile revenues for these companies have grown 18% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare sector?
| PK Market | 0.96% | |
| Healthcare | 0.28% | |
| Life Sciences | 6.01% | |
| Pharma | 0.073% | |
| Medical Equipment | 0% | |
| Healthtech | 0% | |
| Biotech | 0% | |
| Healthcare Services | -0.27% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 70.4x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
- Investors are most pessimistic about the Healthcare Services industry, which is trading below its 3-year average of 39.9x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 74% over the next 5 years.
- This is better than its past earnings decline of 66% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 74% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ABOT Abbott Laboratories (Pakistan) | PK₨398.00 | 1.9% +PK₨720.5m | -38.8% | PE29x | |
| MACTER Macter International | PK₨104.90 | 7.3% +PK₨328.9m | -16.6% | n/a | |
| SAPL sanofi-aventis Pakistan | PK₨756.00 | 2.2% +PK₨154.3m | -13.1% | PE43.7x | |
| FEROZ Ferozsons Laboratories | PK₨139.09 | 1.6% +PK₨96.1m | -32.1% | PE36.9x | |
| CPHL Citi Pharma | PK₨22.36 | 1.7% +PK₨86.8m | -24.3% | PE8.3x |